CD8A and neoplasm: The tumor antigens are then continuously presented to CD8+ and CD4+ T lymphocytes in the form of antigen peptide-MHC (p-MHC) molecular complexes to generate a large number of CTL and memory T cells, which can kill the tumor, reduce the risk of metastasis and prolong the survival time of patients (21).